StockWatch
·
Pharmaceuticals
Board Meeting31 Oct 2026, 07:12 pm

Cresanto Global Board Meeting on Nov 5 to Approve Q2 FY27 Results

AI Summary

Cresanto Global Ltd has announced that its Board of Directors will convene on November 5, 2026, to consider and approve the un-audited financial results for the second quarter ended September 30, 2026. The meeting will also include noting the Limited Review Report for the same period. Additionally, the company has informed about a trading window closure for designated persons from October 1, 2026, to November 7, 2026, to prevent insider trading around the financial results announcement.

Key Highlights

  • Board meeting scheduled for November 5, 2026.
  • To approve un-audited financial results for Q2 FY27.
  • Limited Review Report for Q2 FY27 to be noted.
  • Trading window closure from Oct 1 to Nov 7, 2026.